Hypothalamic Ahi1 mediates feeding behavior through interaction with 5-HT 2C receptor

Journal of Biological Chemistry

Volumn 287, Issue 3, 2012, Pages 2237-2246

  Wang, Hao ^a   Huang, Zhenbo ^a   Huang, Liansha ^b   Niu, Shaona ^c   Rao, Xiurong ^a   Xu, Jing ^a   Kong, Hui ^a   Yang, Jianzhong ^d   Yang, Chuan ^e   Wu, Donghai ^a   Li, Shihua ^f   Li, Xiao Jiang ^f   Liu, Tonghua ^b   Sheng, Guoqing ^a,g  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c LINYI PEOPLE'S HOSPITAL   (China)

^d Red Cross Hospital of Yunnan Province   (China)

^e SUN YAT SEN UNIVERSITY   (China)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Science Park   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; COLOCALIZATION; FEEDING BEHAVIOR; FOOD INTAKE; NEUROPEPTIDE Y; SEROTONIN RECEPTORS; SIGNALING PATHWAYS;

PIGMENTS;

FEEDING;

ABELSON HELPER INTEGRATION SITE 1 PROTEIN; ADAPTOR PROTEIN; AHI1 PROTEIN; GLUCOSE; INSULIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DIET RESTRICTION; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION; GENE SILENCING; GLUCOSE TOLERANCE TEST; HYPOTHALAMUS; INSULIN TOLERANCE TEST; LYSOSOME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; WEIGHT REDUCTION;

ANIMALS; APPETITE REGULATION; FEEDING BEHAVIOR; HUMANS; HYPOTHALAMUS; MALE; MICE; NERVE TISSUE PROTEINS; NEUROPEPTIDE Y; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 84862922111     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.277871     Document Type: Article

References (64)

1. Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S., and Schwartz, M. W. (2006) Central nervous system control of food intake and body weight. Nature 443, 289-295 (Pubitemid 44435142)
2. Sandoval, D., Cota, D., and Seeley, R. J. (2008) The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation. Annu. Rev. Physiol. 70, 513-535 (Pubitemid 351738190)
3. Jespersen, S., and Scheel-Krüger, J. (1973) Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia. J. Pharm. Pharmacol. 25, 49-54
4. Shor-Posner, G., Grinker, J. A., Marinescu, C., Brown, O., and Leibowitz, S. F. (1986) Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res. Bull. 17, 663-671 (Pubitemid 17200136)
5. Vickers, S. P., Benwell, K. R., Porter, R. H., Bickerdike, M. J., Kennett, G. A., and Dourish, C. T. (2000) Comparative effects of continuous infusion of mCPP, Ro 60-0175, and D-fenfluramine on food intake, water intake, body weight, and locomotor activity in rats. Br. J. Pharmacol. 130, 1305-1314 (Pubitemid 30488594)
6. Pinder, R. M., Brogden, R. N., Sawyer, P. R., Speight, T. M., and Avery, G. S. (1975) Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10, 241-323
7. Vezzosi, D., Cartier, D., Régnier, C., Otal, P., Bennet, A., Parmentier, F., Plantavid, M., Lacroix, A., Lefebvre, H., and Caron, P. (2007) Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur. J. Endocrinol. 156, 21-31 (Pubitemid 46553900)
8. Kring, S. I., Werge, T., Holst, C., Toubro, S., Astrup, A., Hansen, T., Pedersen, O., and Sørensen, T. I. (2009) Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes. PLoS One 4, e6696
9. Zhou, L., Sutton, G. M., Rochford, J. J., Semple, R. K., Lam, D. D., Oksanen, L. J., Thornton-Jones, Z. D., Clifton, P. G., Yueh, C. Y., Evans, M. L., McCrimmon, R. J., Elmquist, J. K., Butler, A. A., and Heisler, L. K. (2007) Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab. 6, 398-405 (Pubitemid 350012006)
10. De Vry, J., and Schreiber, R. (2000) Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action. Neurosci. Biobehav. Rev. 24, 341-353 (Pubitemid 30227250)
11. Nonogaki, K., Strack, A. M., Dallman, M. F., and Tecott, L. H. (1998) Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat. Med. 4, 1152-1156 (Pubitemid 28468828)
12. Tecott, L. H., Sun, L. M., Akana, S. F., Strack, A. M., Lowenstein, D. H., Dallman, M. F., and Julius, D. (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374, 542-546
13. Vickers, S. P., Easton, N., Webster, L. J., Wyatt, A., Bickerdike, M. J., Dourish, C. T., and Kennett, G. A. (2003) Oral adnmnistration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology (Berl.) 167, 274-280 (Pubitemid 36712974)
14. Brown, C. M., and Coscina, D. V. (1995) Ineffectiveness of hypothalamic serotonin to block neuropeptide Y-induced feeding. Pharmacol. Biochem. Behav. 51, 641-646
15. Heisler, L. K., Cowley, M. A., Tecott, L. H., Fan, W., Low, M. J., Smart, J. L., Rubinstein, M., Tatro, J. B., Marcus, J. N., Holstege, H., Lee, C. E., Cone, R. D., and Elmquist, J. K. (2002) Activation of central melanocortin pathways by fenfluramine. Science 297, 609-611 (Pubitemid 34815346)
16. Rogers, P., McKibbin, P. E., and Williams, G. (1991) Acute fenfluramine administration reduces neuropeptide Y concentrations in specific hypothalamic regions of the rat: possible implications for the anorectic effect of fenfluramine. Peptides 12, 251-255
17. Poirier, Y., Kozak, C., and Jolicoeur, P. (1988) Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA. J. Virol. 62, 3985-3992
18. Dixon-Salazar, T., Silhavy, J. L., Marsh, S. E., Louie, C. M., Scott, L. C., Gururaj, A., Al-Gazali, L., Al-Tawari, A. A., Kayserili, H., Sztriha, L., and Gleeson, J. G. (2004) Mutations in the AHI1 gene, encoding jouberin, cause Joubert syndrome with cortical polymicrogyria. Am. J. Hum. Genet. 75, 979-987 (Pubitemid 39532068)
19. Utsch, B., Sayer, J. A., Attanasio, M., Pereira, R. R., Eccles, M., Hennies, H. C., Otto, E. A., and Hildebrandt, F. (2006) Identification of the first AHI1 gene mutations in nephronophthisis-associated Joubert syndrome. Pediatr. Nephrol. 21, 32-35 (Pubitemid 43040191)
20. Valente, E. M., Brancati, F., Silhavy, J. L., Castori, M., Marsh, S. E., Barrano, G., Bertini, E., Boltshauser, E., Zaki, M. S., Abdel-Aleem, A., Abdel-Salam, G. M., Bellacchio, E., Battini, R., Cruse, R. P., Dobyns, W. B., Krishnamoorthy, K. S., Lagier-Tourenne, C., Magee, A., Pascual-Castroviejo, I., Salpietro, C. D., Sarco, D., Dallapiccola, B., and Gleeson, J. G. (2006) AHI1 gene mutations cause specific forms of Joubert syndrome-related disorders. Ann. Neurol. 59, 527-534 (Pubitemid 43358074)
21. Doering, J. E., Kane, K., Hsiao, Y. C., Yao, C., Shi, B., Slowik, A. D., Dhagat, B., Scott, D. D., Ault, J. G., Page-McCaw, P. S., and Ferland, R. J. (2008) Species differences in the expression of Ahi1, a protein implicated in the neurodevelopmental disorder Joubert syndrome, with preferential accumulation to stigmoid bodies. J. Comp. Neurol. 511, 238-256
22. Ferland, R. J., Eyaid, W., Collura, R. V., Tully, L. D., Hill, R. S., Al-Nouri, D., Al-Rumayyan, A., Topcu, M., Gascon, G., Bodell, A., Shugart, Y. Y., Ruvolo, M., and Walsh, C. A. (2004) Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. Nat. Genet. 36, 1008-1013 (Pubitemid 39167500)
23. Sheng, G., Xu, X., Lin, Y. F., Wang, C. E., Rong, J., Cheng, D., Peng, J., Jiang, X., Li, S. H., and Li, X. J. (2008) Huntingtin-associated protein 1 interacts with Ahi1 to regulate cerebellar and brainstem development in mice. J. Clin. Invest. 118, 2785-2795
24. Salonen, J. T., Uimari, P., Aalto, J. M., Pirskanen, M., Kaikkonen, J., Todorova, B., Hyppönen, J., Korhonen, V. P., Asikainen, J., Devine, C., Tuomainen, T. P., Luedemann, J., Nauck, M., Kerner, W., Stephens, R. H., New, J. P., Ollier, W. E., Gibson, J. M., Payton, A., Horan, M. A., Pendleton, N., Mahoney, W., Meyre, D., Delplanque, J., Froguel, P., Luzzatto, O., Yakir, B., and Darvasi, A. (2007) Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am. J. Hum. Genet. 81, 338-345 (Pubitemid 47236080)
25. Prior, M. J., Foletta, V. C., Jowett, J. B., Segal, D. H., Carless, M. A., Curran, J. E., Dyer, T. D., Moses, E. K., McAinch, A. J., Konstantopoulos, N., Bozaoglu, K., Collier, G. R., Cameron-Smith, D., Blangero, J., and Walder, K. R. (2010) The characterization of Abelson helper integration site-1 in skeletal muscle and its links to the metabolic syndrome. Metabolism 59, 1057-1064
26. Han, S. B., Choi, B. I., Lee, D., Kee, S. H., Kim, H. S., Sun, W., and Kim, H. (2009) Regulation of AHI1 expression in adult rat brain: Implication in hypothalamic feeding control. Biochem. Biophys. Res. Commun. 390, 535-540
27. Niu, S. N., Huang, Z. B., Wang, H., Rao, X. R., Kong, H., Xu, J., Li, X. J., Yang, C., and Sheng, G. Q. (2011) Brainstem Hap1-Ahi1 is involved in insulin-mediated feeding control. FEBS Lett. 585, 85-91
28. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
29. Yuan, J. S., Reed, A., Chen, F., and Stewart, C. N., Jr. (2006) Statistical analysis of real-time PCR data. BMC Bioinformatics 7, 85
30. Sutton, G. M., Trevaskis, J. L., Hulver, M. W., McMillan, R. P., Markward, N. J., Babin, M. J., Meyer, E. A., and Butler, A. A. (2006) Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 147, 2183-2196
31. Swandulla, D., and Misgeld, U. (1990) Development and properties of synaptic mechanisms in a network of rat hypothalamic neurons grown in culture. J. Neurophysiol. 64, 715-726 (Pubitemid 20319437)
32. Jiang, X., Hanna, Z., Kaouass, M., Girard, L., and Jolicoeur, P. (2002) Ahi-1, a novel gene encoding a modular protein with WD40-repeat and SH3 domains, is targeted by the Ahi-1 and Mis-2 provirus integrations. J. Virol. 76, 9046-9059 (Pubitemid 34919863)
33. Keller, L. C., Geimer, S., Romijn, E., Yates, J., 3rd, Zamora, I., and Marshall, W. F. (2009) Molecular architecture of the centriole proteome: the conserved WD40 domain protein POC1 is required for centriole duplication and length control. Mol. Biol. Cell 20, 1150-1166
34. Louie, C. M., Caridi, G., Lopes, V. S., Brancati, F., Kispert, A., Lancaster, M. A., Schlossman, A. M., Otto, E. A., Leitges, M., Gröne, H. J., Lopez, I., Gudiseva, H. V., O'Toole, J. F., Vallespin, E., Ayyagari, R., Ayuso, C., Cremers, F. P., den Hollander, A. I., Koenekoop, R. K., Dallapiccola, B., Ghiggeri, G. M., Hildebrandt, F., Valente, E. M., Williams, D. S., and Gleeson, J. G. (2010) AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis. Nat. Genet. 42, 175-180
35. Scheepers, F. E., Gespen de Wied, C. C., and Kahn, R. S. (2001) The effect of olanzapine treatment onm-chlorophenylpiperazine-induced hormone release in schizophrenia. J. Clin. Psychopharmacol. 21, 575-582 (Pubitemid 33116656)
36. Heisler, L. K., Cowley, M. A., Kishi, T., Tecott, L. H., Fan, W., Low, M. J., Smart, J. L., Rubinstein, M., Tatro, J. B., Zigman, J. M., Cone, R. D., and Elmquist, J. K. (2003) Central serotonin and melanocortin pathways regulating energy homeostasis. Ann. N.Y. Acad. Sci. 994, 169-174 (Pubitemid 36793864)
37. Neer, E. J., Schmidt, C. J., Nambudripad, R., and Smith, T. F. (1994) The ancient regulatory-protein family of WD-repeat proteins. Nature 371, 297-300 (Pubitemid 24300613)
38. Sicheri, F., Moarefi, I., and Kuriyan, J. (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609 (Pubitemid 27087567)
39. Koch, C. A., Anderson, D., Moran, M. F., Ellis, C., and Pawson, T. (1991) SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674 (Pubitemid 21916987)
40. Hsiao, Y. C., Tong, Z. J., Westfall, J. E., Ault, J. G., Page-McCaw, P. S., and Ferland, R. J. (2009) Ahi1, whose human ortholog is mutated in Joubert syndrome, is required for Rab8a localization, ciliogenesis and vesicle trafficking. Hum. Mol. Genet. 18, 3926-3941
41. Dryden, S., McCarthy, H. D., Malabu, U. H., Ware, M., and Williams, G. (1993) Increased neuropeptide Y concentrations in specific hypothalamic nuclei of the rat following treatment with methysergide: evidence that NPY may mediate serotonin's effects on food intake. Peptides 14, 791-796
42. Currie, P. J., Saxena, N., and Tu, A. Y. (1999) 5-HT(2A/2C) receptor antagonists in the paraventricular nucleus attenuate the action of DOI on NPY-stimulated eating. Neuroreport 10, 3033-3036 (Pubitemid 29507774)
43. Hsiao, S. H., Chung, H. H., Inui, A., Tong, Y. C., and Cheng, J. T. (2006) Inhibitory effect of 5-hydroxytryptamine on hyperphagia in mice with genetic overexpression of neuropeptide Y. Neurosci. Lett. 394, 256-258 (Pubitemid 43144861)
44. Boston, B. A., Blaydon, K. M., Varnerin, J., and Cone, R. D. (1997) Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278, 1641-1644 (Pubitemid 27516287)
45. Cone, R. D. (2005) Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8, 571-578
46. Lee, Y. S., Challis, B. G., Thompson, D. A., Yeo, G. S., Keogh, J. M., Madonna, M. E., Wraight, V., Sims, M., Vatin, V., Meyre, D., Shield, J., Burren, C., Ibrahim, Z., Cheetham, T., Swift, P., Blackwood, A., Hung, C. C., Wareham, N. J., Froguel, P., Millhauser, G. L., O'Rahilly, S., and Farooqi, I. S. (2006) A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 3, 135-140
47. Biebermann, H., Castañeda, T. R., van Landeghem, F., von Deimling, A., Escher, F., Brabant, G., Hebebrand, J., Hinney, A., Tschöp, M. H., Grüters, A., and Krude, H. (2006)Arole for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 3, 141-146
48. Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., and Cone, R. D. (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168 (Pubitemid 27034218)
49. Adan, R. A., Cone, R. D., Burbach, J. P., and Gispen, W. H. (1994) Differential effects of melanocortin peptides on neural melanocortin receptors. Mol. Pharmacol. 46, 1182-1190
50. Ollmann, M. M., Wilson, B. D., Yang, Y. K., Kerns, J. A., Chen, Y., Gantz, I., and Barsh, G. S. (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135-138 (Pubitemid 27446294)
51. Stanley, B. G., and Leibowitz, S. F. (1984) Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 35, 2635-2642 (Pubitemid 15221101)
52. Lam, D. D., Przydzial, M. J., Ridley, S. H., Yeo, G. S., Rochford, J. J., O'Rahilly, S., and Heisler, L. K. (2008) Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149, 1323-1328 (Pubitemid 351397929)
53. Ascher-Svanum, H., Stensland, M., Zhao, Z., and Kinon, B. J. (2005) Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia. BMC Psychiatry 5, 3
54. L'Italien, G. J., Casey, D. E., Kan, H. J., Carson, W. H., and Marcus, R. N. (2007) Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo. J. Clin. Psychiatry 68, 1510-1516 (Pubitemid 350073397)
55. Nasrallah, H. A., and Newcomer, J. W. (2004) Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. J. Clin. Psychopharmacol. 24, S7-14
56. Kinon, B. J., Bassoon, B. R., Gilmore, J. A., and Tomlinson, G. D. (2001) Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J. Clin. Psychiatry 62, 92-100 (Pubitemid 32199865)
57. Nasrallah, H. (2003) A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 28, Suppl. 1, 83-96
58. Henderson, D. C., Cagliero, E., Copeland, P. M., Borba, C. P., Evins, E., Hayden, D., Weber, M. T., Anderson, E. J., Allison, D. B., Daley, T. B., Schoenfeld, D., and Goff, D. C. (2005) Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch. Gen. Psychiatry 62, 19-28 (Pubitemid 40096067)
59. Nasrallah, H. A. (2008) Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol. Psychiatry 13, 27-35
60. Goodall, E., Oxtoby, C., Richards, R., Watkinson, G., Brown, D., and Silverstone, T. (1988) A clinical trial of the efficacy and acceptability of Dfenfluramine in the treatment of neuroleptic-induced obesity. Br. J. Psychiatry 153, 208-213
61. Kennett, G. A., Whitton, P., Shah, K., and Curzon, G. (1989) Anxiogeniclike effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur. J. Pharmacol. 164, 445-454 (Pubitemid 19146953)
62. Matsui-Sakata, A., Obtain, H., and Sawada, Y. (2005) Receptor occupancy-based analysis of the contributions of various receptors to antipsychoticsinduced weight gain and diabetes mellitus. Drug Metab. Pharmacokinetic. 20, 368-378
63. Garfield, A. S., and Heisler, L. K. (2009) Pharmacological targeting of the serotonergic system for the treatment of obesity. J. Physiol. 587, 49-60
64. Iordanidou, M., Tavridou, A., Vasiliadis, M. V., Arvanitidis, K. I., Petridis, J., Christakidis, D., Vargemezis, V., Bougioukas, G., and Manolopoulos, V. G. (2008) The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians. Pharmacogenet. Genomics 18, 153-159